A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: A gynecologic oncology group study

David Scott Miller, John A. Blessing, Samuel S. Lentz, Steven E. Waggoner, Denise Mackey

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Fingerprint Dive into the research topics of 'A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: A gynecologic oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences